-
admin
Posts
Inside China’s wildest cave basketball court
BEIJING, March 29, 2026 /PRNewswire/ — A news report from chinadaily.com.cn: Beneath the majestic mountains of Guizhou province lie some of nature’s most awestruck wonders:...
Foshan Launches First Provincial-Level International Medical Pilot
Foshan Fosun Chancheng Hospital Sets New Benchmark for Greater Bay Area Healthcare FOSHAN, China, March 29, 2026 /PRNewswire/ — On March 28, Foshan Fosun Chancheng...
Arcutis Presents New Phase 2 Results in Infants with Atopic Dermatitis in Late-Breaking Session Today at the 2026 American Academy of Dermatology Annual Meeting
Investigational ZORYVE® (roflumilast) cream 0.05% was well tolerated with safety findings consistent with prior pediatric experience in the INTEGUMENT program ZORYVE cream improved signs and...
Gelatin Trick 2026 Warning: Does the Viral Gelatin Trick Recipe Actually Work? — Pink Gelatin Trick, Ice Gelatin Trick, Bariatric Jello, and Why Consumers Are Choosing Gelatine Sculpt Instead (New Investigation)
As interest in the gelatin trick surges in 2026, consumers across social platforms and search engines are asking whether the viral recipe actually works —...
Steel Power Male Enhancement Claims Evaluated: Complete SteelPower Performance Report for Men
A 2026 report outlining Steel Power ingredient research, male enhancement supplement positioning, performance claim context, pricing structure, and what the SteelPower formula label discloses for...
Biogen Announces Second Positive Phase 2 Litifilimab Trial in Cutaneous Lupus Erythematosus at 2026 American Academy of Dermatology Annual Meeting, Showing a Significant Reduction in Skin Disease Activity
In the Phase 2 part of the AMETHYST study, litifilimab met the primary endpoint of reduction of disease activity in people living with CLE at...
New England Journal of Medicine Publishes Positive Phase 3 VALOR Trial Results of Brepocitinib in Dermatomyositis
The results of the Phase 3 VALOR trial were published in the New England Journal of Medicine, underscoring the practice-changing potential of brepocitinib 30 mg...
MoonLake announces Week 40 Results from its Phase 3 Clinical Trials of Sonelokimab in Hidradenitis Suppurativa at the 2026 AAD Annual Meeting
Results from the Phase 3 VELA clinical trials in adults with moderate-to-severe hidradenitis suppurativa (HS) show that clinical responses continue to improve to Week 40,...
Record Your Passion: TORRAS Partners with Portugal Football for the Season Ahead
NEW YORK, March 28, 2026 /PRNewswire/ — In 2026, Portugal will begin a World Cup journey with special significance. After missing the last World Cup...
Lianlian DigiTech Reports 2025 Results with 31.9% Revenue Growth and 105.9% Increase in Adjusted Operating Profit
HANGZHOU, China, March 28, 2026 /PRNewswire/ — On March 26, 2026, Hong Kong-listed Lianlian DigiTech Co., Ltd. (“Lianlian DigiTech” or the “Company”; stock code: 2598.HK) released...
